Choroidal drainage good option for acute angle closure

Article

Choroidal drainage can be a safe and effective interventional procedure for patients presenting with acute angle closure secondary to Topiramate toxicity.

Choroidal drainage can be a safe and effective interventional procedure for patients presenting with acute angle closure secondary to Topiramate toxicity, according to a case report published in the December 2007 issue of the Journal of Glaucoma.

Topiramate is an anti-convulsant drug administered to treat certain types of seizures in patients with epilepsy.

Rajul Parikh and co-workers from the Christian Medical College, Vellore and the LV Prasad Eye Institute, Hyderabad, India reported the role of choroidal drainage in a patient with acute bilateral angle closure secondary to cilio-choroidal effusion with Topiramate.

Two-weeks after commencing Topiramate for the management of epilepsy, the patient developed acute bilateral angle closure secondary to cilio-choroidal effusion with lenticulo-corneal touches for which choroidal drainage was performed.

Following the procedure, the anterior chamber deepened, the corneal oedema resolved, choroidals began to resolve and intraocular pressure was controlled without medication. The researchers therefore concluded that, in patients presenting with acute angle closure secondary to Topiramate toxicity, choroidal drainage is a safe and effective interventional procedure.

Recent Videos
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Vikas Chopra at AAO 2024: Advancements in MIGS are transforming patient care
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.